CRDL

Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx(TM), into Brazil, Mexico, and Canada

Monday, October 18, 2021 - 12:27pm

Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease

Key Points: 
  • Cardiol has now received requisite government approvals from health regulators in Brazil, Mexico, and Canada to initiate several additional hospital centers in these countries.
  • Clinical site activation is underway in Brazil and Mexico and the first hospital centers are initiating patient enrollment.
  • The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is being investigated in a Phase II/III outcomes study (the LANCER trial).
  • These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information.

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

Friday, October 15, 2021 - 9:00pm

NEW YORK, Oct. 15, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced the third quarter 2021 performance and quarterly rebalancing of the OTCQX and OTCQB indexes, including the OTCQX Canada Index and the OTCQX Dividend Index.

Key Points: 
  • NEW YORK, Oct. 15, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced the third quarter 2021 performance and quarterly rebalancing of the OTCQX and OTCQB indexes, including the OTCQX Canada Index and the OTCQX Dividend Index.
  • The OTCQX Billion+ Index (.OTCQXBIL), which tracks the performance of $1 billion-plus market cap OTCQX companies, was down 1.7% for the quarter.
  • The OTCQX Composite Index, OTCQX Billion+ Index, OTCQX Dividend Index, OTCQX International Index, OTCQX U.S. Index, OTCQX Banks Index, OTCQX Cannabis Index, and OTCQB Venture Index have minimum liquidity screens to ensure tradability.
  • About OTC Markets Group Inc.
    OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX Best Market, the OTCQB Venture Market and the Pink Open Market for 11,000 U.S. and global securities.

AIST, Toyota, and Toyota Central R&D Labs to Consider Joint Research on Advanced Energy and Environment Technologies

Tuesday, October 12, 2021 - 5:31am

Toyota City, Japan, Oct 12, 2021 - (JCN Newswire) - The National Institute of Advanced Industrial Science and Technology (AIST), Toyota Motor Corporation (Toyota), and Toyota Central R&D Labs., Inc. (Toyota CRDL) announced today that they have commenced discussions on joint research aimed at accelerating development and implementing advanced technologies in the field of energy and the environment.

Key Points: 
  • Toyota City, Japan, Oct 12, 2021 - (JCN Newswire) - The National Institute of Advanced Industrial Science and Technology (AIST), Toyota Motor Corporation (Toyota), and Toyota Central R&D Labs., Inc. (Toyota CRDL) announced today that they have commenced discussions on joint research aimed at accelerating development and implementing advanced technologies in the field of energy and the environment.
  • More specifically, AIST, Toyota, and Toyota CRDL, will discuss joint research on the following four topics:
    Using energy models developed by AIST, the three parties will analyze the impact on energy use systems occasioned by future trends in energy-related technologies, energy environment policies, and other societal changes.
  • The three parties will seek to popularize vehicles equipped with solar power generation systems, which convert light energy into electrical energy.
  • Toyota and Toyota CRDL wish to see advanced technologies aimed at carbon neutrality implemented across society at the earliest opportunity.